Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
Go back to Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop| (NASDAQ: EVAX) | Delayed: 3.05 +0.01 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $ | |||
| Open | $3.02 | 52 Week Low | $ | |||
| Day High | $3.15 | P/E | N/A | |||
| Day Low | $2.96 | EPS | $ | |||
| Volume | 10,386 | |||||

